Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

Viridian Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 14, 2021 / 01:00PM GMT
Release Date Price: $17.88 (-0.61%)
Michael Higgins
Ladenburg Thalmann - Analyst

Good morning, everyone. Thank you for joining us at the Ladenburg Thalmann Virtual Healthcare Conference. My name is Michael Higgins, Managing Director, Senior Biotech Analyst here at the firm. I'm pleased to introduce today a Company I cover, Viridian Therapeutics. A friend of mine, [Jon] Violin, is Co-Founder and CEO. Jon, I'll let you take it away. We will have a little time at the end then for Q&A. Correct?

Jon Violin
Viridian Therapeutics, Inc. - Co-Founder & CEO

Great. Yes, thanks, Michael, and thanks, everyone, for joining. So given that we are a relatively new Company still, I thought I would go through our corporate deck, but I do want to save some time for Q&A. So we will probably give a light touch to a few of our slides here. So thanks again for spending your time with us.

And of course before we get started, please see our SEC filings for our risk statements. I will be making forward-looking statements. And as an overview of Viridian, so we formed the Company last year and are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot